Exact Mass: 795.4111121999999

Exact Mass Matches: 795.4111121999999

Found 28 metabolites which its exact mass value is equals to given mass value 795.4111121999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cyclo(aspartylleucylthreonylvalyltyrosylphenylalanylglycyl)

2-[17-Benzyl-3,6,9,12,15,18,21-heptahydroxy-11-(1-hydroxyethyl)-14-[(4-hydroxyphenyl)methyl]-5-(2-methylpropyl)-8-(propan-2-yl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1(21),3,6,9,12,15,18-heptaen-2-yl]acetate

C39H53N7O11 (795.3802868)

Constituent of the fruit peel of Citrus medica variety sarcodactylis. Cyclo(aspartylleucylthreonylvalyltyrosylphenylalanylglycyl) is found in citrus.

An aprotoxin having the common aprotoxin cyclodepsipeptide skeleton with a double bond in the polyketide unit. It is isolated from Lyngbya bouillonii and exhibits cytotoxic activity against several cancer cell lines derived from colon, cervix, and bone.

cyclo(-Gly-Asp-Leu-Thr-Val-Tyr-Phe-)

C39H53N7O11 (795.3802868)

Cyclo-(Gly-Asp-Leu-Thr-Val-Tyr-Phe)

C39H53N7O11 (795.3802868)

nomega-(2-acetamido-3,4,6-tri-o-benzyl-2-deoxy-beta-d-glucopyranosyl)-nalpha-(tert-butoxycarbonyl)-l-asparagine benzyl ester

C45H53N3O10 (795.3730758)

Endothelin (16-21) trifluoroacetate salt

Histidyl-leucyl-aspartyl-isoleucyl-isoleucyl-tryptophan

C39H57N9O9 (795.4279032)

Cyclo(aspartylleucylthreonylvalyltyrosylphenylalanylglycyl)

C39H53N7O11 (795.3802868)

soyasaponin III(1-)

C42H67O14- (795.4530582)

The monocarboxylic acid anion formed by removal of a proton from the carboxy group of soyasaponin III. It is the major microspecies present at pH 7.3.

Phosphatidylglycerolphosphate (1,2-di-palmitoleoyl)

C38H69O13P2-3 (795.4213184)

(3S,5S,7Z,12S,17S,20S,23S,28aS)-23-[(2S)-butan-2-yl]-3-tert-butyl-17-(4-methoxybenzyl)-5,19,20,22-tetramethyl-3,4,5,6,11,12,13,14,16,17,19,20,22,23,26,27,28,28a-octadecahydro-1H-12,9-(azeno)pyrrolo[2,1-c][1,19,4,7,10,13]oxathiatetraazacyclohexacosine-1,15,18,21,24-pentone

(3S,5S,7Z,12S,17S,20S,23S,28aS)-23-[(2S)-butan-2-yl]-3-tert-butyl-17-(4-methoxybenzyl)-5,19,20,22-tetramethyl-3,4,5,6,11,12,13,14,16,17,19,20,22,23,26,27,28,28a-octadecahydro-1H-12,9-(azeno)pyrrolo[2,1-c][1,19,4,7,10,13]oxathiatetraazacyclohexacosine-1,15,18,21,24-pentone

C43H65N5O7S (795.460446)

xanthoxycyclin B

C44H57N7O7 (795.4319252)

N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetradeca-4,8,12-trien-2-yl]butanamide

N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetradeca-4,8,12-trien-2-yl]butanamide

C36H61NO18 (795.3888446000001)

N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxypentadeca-4,8,12-trien-2-yl]propanamide

C36H61NO18 (795.3888446000001)

N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhexadeca-4,8,12-trien-2-yl]acetamide

C36H61NO18 (795.3888446000001)

(2R)-2-amino-3-[[3-[(7E,9E,11E,13E,15E,17E,19E)-docosa-7,9,11,13,15,17,19-heptaenoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C44H62NO10P (795.4111121999999)

PS 22:4/13:3;O2

C41H66NO12P (795.4322406)

PS 22:5/12:3;O3

C40H62NO13P (795.3958571999999)

PS 22:6/12:2;O3

C40H62NO13P (795.3958571999999)

PS 34:8;O3

C40H62NO13P (795.3958571999999)

PS 35:7;O2

C41H66NO12P (795.4322406)

SHexCer 36:7;O2

C42H69NO11S (795.4591084)

TREM-1 inhibitory peptide M3

C36H53N13O8 (795.4139858)

TREM-1 inhibitory peptide M3 is a ligand-dependent TREM-1 antagonist. TREM-1 inhibitory peptide M3 can inhibit systemic and pulmonary pro-inflammatory cytokine and chemokine production and attenuate acute lung injury[1].

(15z,17z,19z,21z,23z)-25-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,4,9,29-pentahydroxy-7,11-dioxo-13-(sec-butyl)-12,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylic acid

(15z,17z,19z,21z,23z)-25-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,4,9,29-pentahydroxy-7,11-dioxo-13-(sec-butyl)-12,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylic acid

C40H61NO15 (795.4040996)

[(2s,5s,8s,11s,14s,17s)-17-benzyl-3,6,9,12,15,18,21-heptahydroxy-8-[(1s)-1-hydroxyethyl]-14-[(4-hydroxyphenyl)methyl]-11-isopropyl-5-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1(21),3,6,9,12,15,18-heptaen-2-yl]acetic acid

[(2s,5s,8s,11s,14s,17s)-17-benzyl-3,6,9,12,15,18,21-heptahydroxy-8-[(1s)-1-hydroxyethyl]-14-[(4-hydroxyphenyl)methyl]-11-isopropyl-5-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1(21),3,6,9,12,15,18-heptaen-2-yl]acetic acid

C39H53N7O11 (795.3802868)

(15e,17z,19z,21z,23e)-25-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,4,9,29-pentahydroxy-7,11-dioxo-13-(sec-butyl)-12,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylic acid

(15e,17z,19z,21z,23e)-25-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,4,9,29-pentahydroxy-7,11-dioxo-13-(sec-butyl)-12,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylic acid

C40H61NO15 (795.4040996)

[17-benzyl-3,6,9,12,15,18,21-heptahydroxy-8-(1-hydroxyethyl)-14-[(4-hydroxyphenyl)methyl]-11-isopropyl-5-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1(21),3,6,9,12,15,18-heptaen-2-yl]acetic acid

[17-benzyl-3,6,9,12,15,18,21-heptahydroxy-8-(1-hydroxyethyl)-14-[(4-hydroxyphenyl)methyl]-11-isopropyl-5-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1(21),3,6,9,12,15,18-heptaen-2-yl]acetic acid

C39H53N7O11 (795.3802868)